Literature DB >> 17008795

Morphologic, phenotypic and functional characteristics of endothelial cells derived from human hepatic cavernous hemangioma.

Wen-Jian Zhang1, Li-Ya Ye, Lian-Qiu Wu, Yu-Ling Xin, Feng Gu, Ji-Xiao Niu, Zhi-Hua Yang, Guang-Jin Zhu, Georges E Grau, Jin-Ning Lou.   

Abstract

BACKGROUNDS/AIMS: The pathogenesis of cavernous hemangiomas is largely unknown, and it is speculated that abnormal vasculogenesis and angiogenesis may be involved. In this study, the characteristics of cavernous hemangioma endothelial cells (CHECs) derived from the human liver were analyzed in terms of morphology, phenotype and function and compared with human liver sinusoidal endothelial cells (LSECs). METHODS AND
RESULTS: By transmission electron microscopy, abnormally expanded endoplasmic reticulum (ER) and similarly arranged cytoplasmic vacuoles were only found in CHECs. Phenotypic analysis showed that the expression of alphavbeta3 was significantly increased in CHECs. mRNA expression of vascular endothelial growth factor A, and angiopoietins 1 and 2 was significantly increased in CHECs compared to LSECs. The functional analysis indicated that CHECs released more vascular endothelial growth factor A, produced significantly more pro-matrix metalloproteinase 2 (pro-MMP2) and activated MMP2, and exhibited higher procoagulant and fibrinolytic activities compared with LSECs. Confocal microscopy revealed that MMP2 was concentrated in some cytoplasmic granules of CHECs and was consistent with the distribution of expanded ER. CHECs exhibited more activated angiogenesis capacity and formed abnormal capillary-like structures in vitro.
CONCLUSION: These results suggested that endothelial cells (ECs) derived from human cavernous hemangiomas differ from normal ECs in morphology, phenotype and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008795     DOI: 10.1159/000095965

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

1.  Recurrent giant hemangiomas of liver: Report of two rare cases with literature review.

Authors:  Hongfa Zhu; Khaled Obeidat; Jie Ouyang; Sasan Roayaie; Myron E Schwartz; Swan N Thung
Journal:  World J Gastrointest Surg       Date:  2012-11-27

Review 2.  New insights into host-pathogen interactions during Entamoeba histolytica liver infection.

Authors:  D M Faust; J Marquay Markiewicz; J Santi-Rocca; N Guillen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

3.  A case of a ruptured sclerosing liver hemangioma.

Authors:  Haris Papafragkakis; Martin Moehlen; Monica T Garcia-Buitrago; Beatrice Madrazo; Eddie Island; Paul Martin
Journal:  Int J Hepatol       Date:  2011-05-31

4.  Kasabach-Merritt phenomenon with concurrent appearance of antiphospholipid antibodies in a patient with giant liver haemangioma.

Authors:  Hiroyuki Nakamura; Yuichiro Fujieda; Masaru Kato; Tatsuya Atsumi
Journal:  Rheumatol Adv Pract       Date:  2018-10-24

5.  The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in liver hemangioma: a preliminary study.

Authors:  Oskar Kornasiewicz; Marcin Debski; Marta Stepnowska; Anna Szałas; Ewa Bar-Andziak; Marek Krawczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

6.  Giant cavernous hepatic hemangioma shrunk by use of sorafenib.

Authors:  Satoyoshi Yamashita; Kohsuke Okita; Katsunori Harada; Atsuyoshi Hirano; Teruaki Kimura; Akira Kato; Kiwamu Okita
Journal:  Clin J Gastroenterol       Date:  2012-11-29

7.  A hepatic sclerosed hemangioma with significant morphological change over a period of 10 years: a case report.

Authors:  Yoshitaka Shimada; Yoshihito Takahashi; Hiroyoshi Iguchi; Hitoshi Yamazaki; Hidekazu Tsunoda; Masaaki Watanabe; Masaya Oda; Hiroaki Yokomori
Journal:  J Med Case Rep       Date:  2013-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.